Longitudinal genetically detectable minimal residual disease by fluorescence hybridization confers a poor prognosis in myeloma

Longitudinal genetically detectable minimal residual disease by fluorescence hybridization confers a poor prognosis in myeloma

Background: Deeper depth of response (DpR) after induction therapy, especially gain of negative minimal residual disease (MRD), has been linked to prolonged survival in multiple myeloma (MM). However, flow-MRD examination focuses on the numbers but not on the biological characteristics of residual p...

Full description

Bibliographic Details
Main Authors:	Jian Cui, Tengteng Yu, Rui Lv, Jiahui Liu, Huishou Fan, Wenqiang Yan, Jingyu Xu, Chenxing Du, Shuhui Deng, Weiwei Sui, Matthew Ho, Yan Xu, Kenneth C. Anderson, Xifeng Dong, Lugui Qiu, Gang An
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-01-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/17588359231221340

Similar Items

P910: DOES MINIMAL RESIDUAL DISEASE OF STEM CELL COLLECTION HAVE PROGNOSTIC IMPACT ON PATIENTS WITH MULTIPLE MYELOMA?
by: X. Jingyu, et al.
Published: (2022-06-01)

Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
by: Wenqiang Yan, et al.
Published: (2023-07-01)

P935: EARLY RELAPSE WITHIN 18 MONTHS (ER18) IS A POWERFUL DYNAMIC PREDICTOR FOR PROGNOSIS AND COULD REVISE STATIC RISK DISTRIBUTION IN PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA
by: Wenqiang Yan, et al.
Published: (2023-08-01)

The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma
by: Huihsou Fan, et al.
Published: (2023-12-01)

PB2005: BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: A REAL-WORLD STUDY OF CHINA
by: X. Jingyu, et al.
Published: (2022-06-01)

The age-dependent changes in risk weights of the prognostic factors for multiple myeloma
by: Chenxing Du, et al.
Published: (2023-12-01)

P844: GLOBAL CHARACTERIZATION OF MONOCYTE REVEALS A STRESS SIGNATURE INDUCED BY MULTIPLE MYELOMA BY SINGLE-CELL RNA SEQUENCING
by: Jian Cui, et al.
Published: (2023-08-01)

Immunotherapy for multiple myeloma: new chances and hope
by: Jingyu Xu, et al.
Published: (2023-10-01)

P806: TRACKING THE CLONAL EVOLUTION AND DRUG RESISTANCE PATHWAY OF NEWLY DIAGNOSED MULTIPLE MYELOMA THROUGH SINGLE-CELL RNA SEQUENCING
by: Jian Cui, et al.
Published: (2023-08-01)

Low TYROBP expression predicts poor prognosis in multiple myeloma
by: Hong Luo, et al.
Published: (2024-03-01)

Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma
by: Junqiang Lv, et al.
Published: (2022-11-01)

PB2080: LOW DUP1 EXPRESSION PREDICTS POOR PROGNOSIS IN MULTIPLE MYELOMA
by: Jinfeng Lu, et al.
Published: (2023-08-01)

Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study
by: Huishou Fan, et al.
Published: (2023-01-01)

Over expression of METRN predicts poor clinical prognosis in colorectal cancer
by: Xin Xu, et al.
Published: (2020-03-01)

The TT Genotype of the <i>KIAA1524 rs2278911</i> Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma
by: Aneta Szudy-Szczyrek, et al.
Published: (2023-03-01)

Cluster analysis of autoencoder-extracted FDG PET/CT features identifies multiple myeloma patients with poor prognosis
by: Hyunjong Lee, et al.
Published: (2023-05-01)

Severe and continuous immunoparesis during induction or maintenance therapy in nontransplant patients with multiple myeloma is a sign of poor prognosis
by: Ying Chen, et al.
Published: (2024-12-01)

Increased Monocytic Myeloid-Derived Suppressor Cells in Whole Blood Predict Poor Prognosis in Patients with Plasma Cell Myeloma
by: Mi-Hyun Bae, et al.
Published: (2021-10-01)

Dual Negativity of CD56 and CD117 Links to Unfavorable Cytogenetic Abnormalities and Predicts Poor Prognosis in Multiple Myeloma
by: Dong Zheng, et al.
Published: (2022-11-01)

Hyperdiploid Multiple Myeloma with Novel Complex Structural Chromosome Abnormalities Associated with Poor Prognosis : A Rare Case Report
by: Ravindran Ankathil, et al.
Published: (2021-07-01)

The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma
by: Ke Huang, et al.
Published: (2022-07-01)

Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.
by: Xin Jin, et al.
Published: (2024-01-01)

Dysregulation of LINC00324 promotes poor prognosis in patients with glioma
by: Xin Jin, et al.
Published: (2024-01-01)

Multiple myeloma–derived miR‐27b‐3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment
by: Xiaojing Wei, et al.
Published: (2023-01-01)

Novel Insights into the Initiation, Evolution, and Progression of Multiple Myeloma by Multi-Omics Investigation
by: Lixin Gong, et al.
Published: (2024-01-01)

S174: HIGH LEVEL OF CIRCULATING TUMOUR DNA AT DIAGNOSIS CORRELATES WITH DISEASE SPREADING AND DEFINES MULTIPLE MYELOMA PATIENTS WITH POOR PROGNOSIS
by: M. Martello, et al.
Published: (2022-06-01)

High FAAP24 expression reveals poor prognosis and an immunosuppressive microenvironment shaping in AML
by: Xiebing Bao, et al.
Published: (2023-06-01)

RETRACTED: CDK14 expression is elevated in patients with non-small cell lung cancer and correlated with poor prognosis
by: Yong Yang, et al.
Published: (2021-10-01)

Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma
by: Zhang Y, et al.
Published: (2023-02-01)

Clinical Characteristics and Prognosis of Multiple Myeloma With Myelomatous Pleural Effusion: A Retrospective Single-Center Study
by: Liang Gao BS, et al.
Published: (2022-10-01)

JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma
by: Honggang Liu, et al.
Published: (2023-07-01)

The role of serum-free light chain ratios in the prediction of poor prognosis in multiple myeloma patients: a systematic review and meta-analysis
by: Dan Cao, et al.
Published: (2022-12-01)

Poor prognosis of young adults with type 1 diabetes: a longitudinal study.
by: Bryden, K, et al.
Published: (2003)

Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV—Unmutated Chronic Lymphocytic Leukemia
by: Dipnarine Maharaj, et al.
Published: (2020-12-01)

Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis
by: Yuan Li, et al.
Published: (2023-03-01)

Impact of the Stress Hyperglycemia Ratio on In-Hospital and Long-Term Poor Prognosis in Patients with Acute Myocarditis
by: Yan Zhao, et al.
Published: (2023-04-01)

Lowered expression level of INSC predicts poor prognosis in patients with colon cancer
by: Yan Li, et al.
Published: (2023-07-01)

Poor Prognosis in Acute Myeloid Leukemia Patients with Monosomal Karyotype
by: Junqing Xu, et al.
Published: (2017-05-01)

A Minimal Subset of Seven Genes Associated with Tumor Hepatocyte Differentiation Predicts a Poor Prognosis in Human Hepatocellular Carcinoma
by: Matthis Desoteux, et al.
Published: (2021-11-01)

P803: CRIP1 INDUCES PIS RESISTANCE BY FORMING A COMPLEX WITH USP7/PA200 AND ENHANCING PROTEASOME ACTIVITY AND AUTOPHAGY IN MULTIPLE MYELOMA
by: Zhen Yu, et al.
Published: (2023-08-01)